Intrathecal therapy for cancer pain management

Revista de la Sociedad Espanola del Dolor

Volumn 17, Issue 3, 2010, Pages 162-168

  De Leon Casasola O ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Acute pain; Cancer; Chronic pain; Intrathecal therapy

Indexed keywords

BUPIVACAINE; CLONIDINE; FENTANYL; HYDROMORPHONE; METHADONE; MORPHINE; OMEGA CONOTOXIN MVIIA; OPIATE; OXYCODONE; OXYMORPHONE; PLACEBO; SUFENTANIL;

ADD ON THERAPY; ANALGESIA; ANXIETY; CANCER PAIN; CANCER SURVIVAL; CATHETER COMPLICATION; CHRONIC PAIN; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; DIZZINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; EPIDURAL CATHETER; GAIT DISORDER; GRANULOMA; HALLUCINATION; HEADACHE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; MEMORY DISORDER; MYELOGRAPHY; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; SOMNOLENCE;

EID: 77953328984     PISSN: 11348046     EISSN: 11348046     Source Type: Journal    
DOI: 10.1016/S1134-8046(10)70026-4     Document Type: Review

References (27)

1. rd ed. Skokie, IL: APS; 1992.
2. Jacox A, Carr DB, Payne R, Berde CB, Breitbart W, Cain JM, et al. Management of cancer pain: clinical practice guideline 9. Agency for Health Care Policy and Research pub. 94-0592. Rockville, MD: ACHPR; 1994.
3. Zech D F, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain. 1995;63:65-76.
4. Ferrell BR, Wisdon C, Wenzl C. Quality of life as an outcome variable in management of cancer pain. Cancer. 1989;63:2321.
5. Liebeskind JC. Pain can kill. Pain. 1991;44:3-4.
6. Lillemoe KD, Cameron JL, Kaufman HS, Yeo CJ, Pitt HA, Sauter PK. Chemical splanchnicectomy in patients with unresectable pancreatic cancer. Ann Surg. 1993;217:447-57.
7. Cousins MJ, Mather LE. Intrathecal and epidural administration of opioids. Anesthesiology. 1984;61:276-310.
8. Yaksh TL. Spinal opiates: a review of their effect on spinal function with an emphasis on pain processing. Acta Anaesthesiol Scand. 1987;31 Suppl 85:25.
9. Du Pen S, Kharasch ED, Williams A, Peterson DG, Sloan DC, Hasche-Klunder H, et al. Chronic epidural bupivacaine-opioid infusion in intractable cancer pain. Pain. 1992;49:293-300.
10. Wallace MS, Kosck PS, Staats P, Fisher R, Schultz DM, Leong M. Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain. Pain Med. 2009;9:271-81.
11. Smith TJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity and survival. J Clin Oncol. 2002;20:4040-9.
12. Smith TJ, Coyne PJ. Implantable drug delivery systems (IDDS) after failure of comprehensive medical management (CMM) can palliate symptoms in the most refractory cancer pain patients. J Palliat Med. 2005;8:736-42.
13. Bedder MD, Burchiel KJ, Larson A. Cost analysis of two implantable narcotic delivery systems. J Pain Symptom Manage. 1991;6:368.
14. Hassenbusch SJ, Bedder M, Patt RB, Bell GK. Current status of intrathecal therapy for nonmalignant pain management: clinical realities and economic unknowns. J Pain Symptom Manage. 1997;14:S36-48.
15. Deer T, Krames ES, Hassenbusch SJ, Burton A, Caraway D, Dupen S, et al. Polyanalgesic Consensus Conference 2007: Recommendations for the Management of Pain by Intrathecal (Intras-pinal) Drug Delivery: Report of an Interdisciplinary Expert Panel. Neuromodulation. 2007;10:300-28.
16. Johansen MJ, Satterfield WC, Baze WB, Hildebrand KR, Gradert TL, Hassenbusch SJ. Continuous intrathecal infusion of hydromorphone: Safety in the sheep model and clinical implications. Pain Medicine. 2004;5:14-25.
17. Liu S. Spinal Anesthesia. Anesthesiology. 1995;82:1359.
18. Perren F, Buchser E, Chedel D, Hirt L, Maeder P. Vingerhoets F. Spinal cord lesion after long-term intrathecal clonidine and bupivacaine treatment for the management of intractable pain. Pain. 2004;109:189-94.
19. Bernard CM. Cerebrospinal fluid and spinal cord distribution of Baclofen and bupivacaine during slow intrathecal infusion in pigs. Anesthesiology. 2006;105:169-78.
20. Kotob F, De Leon-Casasola OA, Lema M. Intrathecal Infusion Rates of 1 ml/day Improve Narrow Analgesia with Infusion Rates of 0.5 ml/day. Anesthesiology. 2006;105:A347.
21. Hassenbusch S, Portenoy R, Cousins M, Buchser E, Deer TR, Du Pen SL, et al. Polyanalgesic consensus conference: an update on the management of pain by intraspinal drug delivery - report of an expert pane. J Pain Symptom Manage. 2004;27:540-63.
22. Staats PS, Yearwood T, Charapata SG, Presley RW, Wallace MS, Byas-Smith M, et al. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS. A randomized controlled trial. JAMA. 2004;291:63-70.
23. Wallace MS, Rauck R, Fisher R, Charapata SG, Ellis D, Dissanayake S; Ziconotide 98-022 Study Group. Intrathecal ziconotide for severe chronic pain: safety and tolerability results of an open-label, long-term trial. Anesth Analg. 2008;106:628-37.
24. Wallace MS, Kosek PS, Staats P, Fisher R, Schultz DM, Leong M. Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain. Pain Med. 2008;9:271-81. (Pubitemid 351467884)
25. Webster LR, Fakata KL, Fisher R, MineHart M. Open-label multicenter study of combined intrathecal morphine and ziconotide: addition of morphine in patients receiving ziconotide for severe chronic pain. Pain Med. 2008;9:282-90. (Pubitemid 351467885)
26. Wallace M, Charapata S, Fisher R, Byas-Smith M, Staats PS, Mayo M, et al. Intrathecal ziconotide in the treatment of chronic nonmalignant pain: a randomized double-blind placebocontrolled trial. Neuromodulation. 2006;9:75-86.
27. Rauck RL, Wallace MS, Leong MS, Minehart M, Webster LR, Charapata SG, et al. A Randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain. J Pain Symp Manage. 2006;5:393-406.